Infographics - Meperidine (Demerol) Market

Pethidine or meperidine is sold under the brand name of Demerol and it is a synthetic opioid pain medication of phenylpiperidine class. Meperidine is indicated for the treatment of moderate to severe pain. It can be administered as hydrochloride salt in tablets, as a syrup or by intramuscular, subcutaneous or intravenous injection. Due to its toxic metabolite, norpethidine, it is more toxic than other opioid in long term usage. The metabolite of drug has serotonergic effect that could contribute to serotonin syndrome. Meperidine is a widely used opioid in labor and delivery. Meperidine is the preferred painkiller for diverticulitis because it decreases the intestinal intraluminal pressure. This drug is also used for the management of shivering during therapeutic hypothermia, as it provides the greatest reduction in the shivering threshold. It is probable that meperidine can also interact with a number of other medications including muscle relaxants, benzodiazepines, and ethanol. The adverse effects of meperidine administration are primarily those of the opioids as a class: nausea, vomiting, dizziness, diaphoresis, urinary retention, and constipation.

Market Dynamics:

The increasing demand for meperidine, research and development activities in synthesis of meperidine, and the launch of new products are attributed to the growth of the global meperidine (Demerol) market. For instance, according to data shared by European statistical System, a European government agency, on July 2022, at least 1.12 million caesarean sections were performed in the European Union in year 2020. Meperidine is a commonly used drug for the treatment of labor pain and operations. Hence increased surgeries can increase the demand for meperidine and boost the market growth over the forecast period.

Key features of the study:

This report provides an in-depth analysis of the global Meperidine (Demerol) market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global Meperidine (Demerol) market based on the following parameters - Company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Pfizer, Inc., Hikma Pharmaceuticals USA Inc., Epic Pharma, Inc., Vintage Pharmaceuticals, Inc., Sanofi, Janssen Pharmaceuticals, Boehringer Ingelheim, Sun Pharmaceutical, Egalet Corporation, and Mallinckrodt Pharmaceuticals.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global Meperidine (Demerol) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Meperidine (Demerol) market

Detailed Segmentation:

Global Meperidine (Demerol) Market, By Form :
- Tablet
- Injection
- Syrup
Global Meperidine (Demerol) Market, By Application :
- Anesthesia
- Cough Treatment
- Diarrhea Treatment
Global Meperidine (Demerol) Market, By Distribution Channel :
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Meperidine (Demerol) Market, By Region:
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
- Pfizer, Inc.
- Hikma Pharmaceuticals USA Inc.
- Epic Pharma, Inc.
- Vintage Pharmaceuticals, Inc.
- Sanofi
- Janssen Pharmaceuticals
- Boehringer Ingelheim
- Sun Pharmaceutical
- Egalet Corporation
- Mallinckrodt Pharmaceuticals

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Form
  - Market Snapshot, By Application
  - Market Snapshot, By Distribution Channel
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trend Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
Global Meperidine (Demerol) Market - COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
Global Meperidine (Demerol) Market, By Form, 2018-2030, (US$ Million)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018-2030
  - Segment Trends
- Tablet
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Million)
- Injection
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Million)
- Syrup
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Million)
Global Meperidine (Demerol) Market, By Application, 2018-2030, (US$ Million)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018-2030
  - Segment Trends
- Anesthesia
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Million)
- Cough Treatment
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Million)
- Diarrhea Treatment
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Million)
Global Meperidine (Demerol) Market, By Distribution Channel, 2018-2030, (US$ Million)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018-2030
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Million)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Million)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Million)
Global Meperidine (Demerol) Market, By Region, 2018-2030, (US$ Million)
- Introduction
  - Market Share Analysis, By Region, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, For Regions, 2018–2030
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Form, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Form, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Form, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Million)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Form, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Million)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Form, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Million)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Form, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Million)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Pfizer, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Hikma Pharmaceuticals USA Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Epic Pharma, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Vintage Pharmaceuticals, Inc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pfizer, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Hikma Pharmaceuticals USA Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Epic Pharma, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Vintage Pharmaceuticals, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Janssen Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Boehringer Ingelheim
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sun Pharmaceutical
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Egalet Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Mallinckrodt Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
Section
- Research Methodology
- About Us

*Browse 27 market data tables and 31 figures on “Meperidine (Demerol) Market” - Global forecast to 2030

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

MEPERIDINE (DEMEROL) MARKET ANALYSIS

Meperidine (Demerol) Market

Need a Custom Report?

EXISTING CLIENTELE